Exiqon A/S Launches Advanced On-Line Tool for Design of LNA Gapmers for Inhibition of mRNA and lncRNA
9/3/2013 9:54:54 AM
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced an extension to the LNA™ longRNA GapmeR product line with the launch of a novel on-line bioinformatics tool for the design of custom LNA™-gapmer antisense oligonucleotides for specific and efficient inhibition of mRNA and lncRNA.
Help employers find you! Check out all the jobs and post your resume.